Original language | English |
---|---|
Pages (from-to) | 1045-1046 |
Number of pages | 2 |
Journal | JAMA Neurology |
Volume | 78 |
Issue number | 9 |
DOIs |
|
State | Published - Sep 2021 |
Externally published | Yes |
Bibliographical note
Funding Information:reported grants from National Institute of Neurological Disorders and Stroke/National Institutes of Health for an unrelated clinical trial and a training grant from the Fogarty International Center/National Institutes of Health outside the submitted work. Dr Gilman reported nonfinancial support from Oxfendazole Development Group outside the submitted work. No other disclosures were reported.